Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The Rand Corporation is reporting that, in 2022, employers and private insurers paid hospitals an average 254% more than what Medicare would have spent for the same services in the same facilities.
Around the world, 3 of 4 workers who routinely handle information are now using generative AI on the job. And almost half of them are new to the technology, having begun using it only over the past half-year.
Four of five hospital leaders trust the accuracy of their institution’s data. Yet almost half of useable data gets underutilized if not completely untapped for guiding business and clinical decisions.
Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.
When asked to depict people by various descriptors, the image generator delivered lots of results that were unintentionally hilarious for their wild inaccuracy.
Patient advocates state the updated governance would not only integrate coverage for underserved populations but also clamp down on the “games” that Medicare Advantage plans have been known to “play” with Medicaid patients.
The largest hospital system in a large Western state is feeling the heat of negative publicity over how it goes after patients who owe the system money.
Among the 20 million-plus Americans who have unpaid medical bills totaling more than $250, almost a quarter—5 million people—owe between $2,001 and $5,000.
The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.
Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.